News

ICIG appoints new president of WeylChem: Uwe Brunk to succeed Frank Wegener

11. September 2018

Effective October 1, 2018, Dr. Uwe Brunk (56) will join International Chemical Investors Group (ICIG) as President of the WeylChem Group of Companies.

Uwe Brunk holds a PhD in Organic Chemistry from the Technical University in Berlin and an executive MBA from INSEAD. He has accumulated a vast experience in the Fine Chemcials Industry where he spent his entire career. In his last position, he was a member of the management team of the CABB Group as General Manager Acetyls and Managing Director of CABB GmbH among others. Until 2012, he was director of the Agro & Fine Chemicals division at Saltigo GmbH, a subsidiary of Lanxess Group, and can look back on a very broad career at Lanxess and Bayer in production, marketing & sales, strategic planning and general management. Uwe Brunk will be based in Frankfurt-Fechenheim.

“We are delighted, to have been able to attract Uwe Brunk as successor of Frank Wegener. Uwe distinguishes himself as one of few managers with a deep understanding of the fine chemicals industry in line products as well as in custom manufacturing. He is an excellent fit with the capabilities of WeylChem Group”, says Achim Riemann, Managing Director of ICIG.

Following his own wish, Frank Wegener will step down from his position on October 1, 2018 and leave ICIG in due course in order to pursue other career opportunities outside ICIG.

“We thank Frank Wegener for almost 4 years of service for ICIG and WeylChem,” says Patrick Schnitzer, Managing Director at ICIG. “As President, Frank has been instrumental in further building and growing WeylChem as a strong and sustained business platform and setting up the necessary professional organization and internal business processes. Under his leadership, WeylChem has become an important and recognized player in the Fine Chemicals Industry. We wish him all the Best for his professional and private future.”

About WeylChem Group of Companies:

WeylChem Group of Companies is the fine chemicals platform of International Chemicals Investors Group. With ten companies in Europe and North America, WeylChem employs more than 1,970 people. The Group is a global leader in custom manufacturing of specialty chemicals and supplies its customers with a wide range of advanced intermediates and reagents for diverse applications.

For more information about Weylchem Group: www.weylchem.com.

About International Chemical Investors Group

International Chemical Investors is a privately owned industrial group with sales in excess of EUR 2 billion and more than 6,000 employees worldwide. ICIG is focusing on three main platforms: Pharmaceuticals under the CordenPharma brand, Fine Chemicals under the WeylChem brand and Chlorovinyls under the Vynova brand. Since inception in 2004, ICIG has acquired 26 independent chemicals and pharmaceutical businesses in Europe and the United States, all of which have origins in major global chemical or pharmaceutical corporations.

For more information about International Chemical Investors Group: www.ic-investors.com.

Contact:

Gözde Keles
Phone: +49 69 506 820 2587
Email: goezde.keles@weylchem.com

back